0.6653
price down icon2.00%   -0.0136
after-market Handel nachbörslich: .67 0.0047 +0.71%
loading

Finanzdaten der Reviva Pharmaceuticals Holdings Inc-Aktie (RVPH)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Operating Expenses
7.11%
6.073
6.5382 6.2846 8.4625 8.1296
Operating Income/Loss
7.11%
-6.073
-6.5382 -6.2846 -8.4625 -8.1296
Nonoperating Income/Loss
75.28%
0.0273
0.1105 0.0299 0.0967 0.2771
Income/Loss From Continuing Operations Before Tax
5.94%
-6.0457
-6.4276 -6.2547 -8.3658 -7.8525
Income Tax Expense/Benefit
52.58%
0.00795
0.00521 0.00473 - 0.00739
Income/Loss From Continuing Operations After Tax
5.90%
-6.0536
-6.4328 -6.2595 -8.3658 -7.8599
Net Income/Loss
5.90%
-6.0536
-6.4328 -6.2595 -8.3658 -7.8599
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
2.47%
49.85
48.64 1.723 33.80 30.56
Basic Earnings Per Share
7.69%
-0.12
-0.13 -0.15 -0.25 -0.26
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$38.39
price down icon 1.08%
$95.41
price down icon 0.72%
$31.31
price down icon 3.07%
$94.81
price down icon 1.24%
biotechnology ONC
$319.06
price down icon 0.55%
$197.01
price up icon 0.91%
Kapitalisierung:     |  Volumen (24h):